PML and MXD1

  • Number of citations of the paper that reports this interaction (PMID 11430826)
  • 26
  • Data Source:
  • HPRD (in vivo)

PML

MXD1

Gene Name promyelocytic leukemia MAX dimerization protein 1
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 101 interactors: ADH1B ANKRD2 ARID3A ARNT ATF2 ATXN1 AURKA AXIN1 BANP BCL2 BCL6 CASP8AP2 CCNT1 CDK1 CDK2 CDK6 CHFR CREBBP CSNK2A1 DAXX EGFR EIF4E ELF4 EP300 FOS GATA2 HDAC1 HDAC2 HDAC3 HHEX HIPK2 HTT KAT5 KAT6A MAPK11 MAPK14 MDM2 MED7 MXD1 MYB MYC NCOA2 NCOR1 NCOR2 NFKB1 NR3C1 NR4A1 PAWR PAXIP1 PCBD2 PIAS1 PIAS2 PIN1 PLAGL1 PLSCR1 POLR2E PPARG PSMA3 RARA RB1 RBX1 RELA RNF111 RNF125 RNF4 RPL11 RXRA SENP2 SH3GL1 SIAH2 SIN3A SIRT1 SKI SMAD3 SP1 SP100 SRF STAT3 SUMO1 SUMO2 SUMO3 SUV39H1 SYNE2 TDG TERF2IP TGFBR1 TGFBR2 TGIF1 THRA TOPBP1 TP53 TP63 TP73 TRIM24 TRIM27 TRIM69 UBE2I UBE2U UBE3A ZBTB16 ZFYVE9 18 interactors: AKT1 APP CD2 HDAC1 HDAC2 MAX MLX MYC MYCL MYCN PML PRAM1 RPS6KA1 RPS6KB1 SAP30 SIN3A SIN3B SMC3
Entrez ID 5371 4084
HPRD ID 00023 02487
Ensembl ID ENSG00000140464 ENSG00000059728
Uniprot IDs P29590 B7ZLI7 Q05195
PDB IDs 1BOR 1E91 1G1E 1NLW 1PD7 1S5Q
Enriched GO Terms of Interacting Partners?
Tagcloud ?
anthracycline  apl  approaches  appropriately  arsenic  corepressors  curable  cure  deacetylase  effectiveness  explain  explains  incorporation  minority  oncogenes  pathogenetic  plzf  progranulocytic  promoters  ra  rar  recruit  refinement  relapsed  repression  safe  timed  trioxide  vast 
achievable  bio  boolean  broader  bromoindirubin  deeper  easily  ets  extrapolation  fr180204  gsk3  implement  jun  mathematical  modelled  modelling  oxime  pharmacology  programme  prove  qpcr  repression  rescued  sp3  stimulatory  su6656  telomerase  tert  unstable 
Tagcloud (Difference) ?
anthracycline  apl  approaches  appropriately  arsenic  corepressors  curable  cure  deacetylase  effectiveness  explain  explains  incorporation  minority  oncogenes  pathogenetic  plzf  progranulocytic  promoters  ra  rar  recruit  refinement  relapsed  safe  timed  trioxide  vast 
achievable  bio  boolean  broader  bromoindirubin  deeper  easily  ets  extrapolation  fr180204  gsk3  implement  jun  mathematical  modelled  modelling  oxime  pharmacology  programme  prove  qpcr  rescued  sp3  stimulatory  su6656  telomerase  tert  unstable 
Tagcloud (Intersection) ?
repression